JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1998; 32:948-954
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Groote, P.
Right arrow Articles by Lablanche, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Groote, P.
Right arrow Articles by Lablanche, J.-M.

Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure

Pascal de Groote, MDa, Alain Millaire, MD, PhDa, Claude Foucher-Hossein, MD*, Olivier Nugue, MDa, Xavier Marchandise, MD, PhD*, G.érard Ducloux, MDa and Jean-Marc Lablanche, MD, FACCa

a Service de Cardiologie C, Hôpital Cardiologique, Lille, France
* the Service Central de Médecine Nucléaire et Imagerie Fonctionnelle, Hôpital Roger Salengro, Lille, France



View larger version (29K):

[in a new window]
  		Figure 1 Relationship between RVEF and percent of maximal predicted VO2 (top) and between RVEF and SPAP (bottom). The 35 patients with nonsignificant tricuspid regurgitation were excluded. Figure shows individual values, regression line and 95% prediction intervals.

 


View larger version (11K):

[in a new window]
  		Figure 2 Event-free survival curve from cardiovascular mortality and urgent transplantation (UNOS1) for the whole population.

 


View larger version (20K):

[in a new window]
  		Figure 3 Event-free survival curves from cardiac mortality and urgent transplantation (UNOS1) in the two subgroups of patients divided according to the median value of the RVEF (top), of the LVEF (middle) and of the percent of maximal predicted VO2 (bottom).

 


View larger version (13K):

[in a new window]
  		Figure 4 Receiver operating characteristic curve of the RVEF in determining event-free survival from cardiovascular mortality and urgent transplantation at 1 year.

 


View larger version (19K):

[in a new window]
  		Figure 5 Event-free survival curves from cardiovascular mortality and urgent transplantation in the three subgroups of patients divided according to the RVEF <25%, RVEF between 25 and 35% and RVEF ≥35%.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1998 by the American College of Cardiology Foundation.